DD255351A5 - Verfahren zur herstellung von carbocyclischen purinnucleosiden - Google Patents

Verfahren zur herstellung von carbocyclischen purinnucleosiden Download PDF

Info

Publication number
DD255351A5
DD255351A5 DD87300535A DD30053587A DD255351A5 DD 255351 A5 DD255351 A5 DD 255351A5 DD 87300535 A DD87300535 A DD 87300535A DD 30053587 A DD30053587 A DD 30053587A DD 255351 A5 DD255351 A5 DD 255351A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
formula
hydroxyl group
preparation
acid
Prior art date
Application number
DD87300535A
Other languages
German (de)
English (en)
Inventor
Yoshio Taniyama
Takumi Hamana
Ryuji Marumoto
Naoki Yamamoto
Original Assignee
Takeda Chemical Industries Ltd,Jp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd,Jp filed Critical Takeda Chemical Industries Ltd,Jp
Publication of DD255351A5 publication Critical patent/DD255351A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
DD87300535A 1986-03-06 1987-03-06 Verfahren zur herstellung von carbocyclischen purinnucleosiden DD255351A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4939586 1986-03-06

Publications (1)

Publication Number Publication Date
DD255351A5 true DD255351A5 (de) 1988-03-30

Family

ID=12829840

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87300535A DD255351A5 (de) 1986-03-06 1987-03-06 Verfahren zur herstellung von carbocyclischen purinnucleosiden

Country Status (5)

Country Link
JP (1) JPS6310787A (ja)
KR (1) KR870008911A (ja)
CS (1) CS264290B2 (ja)
DD (1) DD255351A5 (ja)
SU (1) SU1561826A3 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
MXPA06005910A (es) 2003-11-25 2006-08-23 3M Innovative Properties Co Sistemas de anillo imidazo sustituido y metodos.
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods

Also Published As

Publication number Publication date
JPS6310787A (ja) 1988-01-18
CS264290B2 (en) 1989-06-13
SU1561826A3 (ru) 1990-04-30
CS151787A2 (en) 1988-09-16
KR870008911A (ko) 1987-10-22

Similar Documents

Publication Publication Date Title
AU596400B2 (en) Carbocyclic purine nucleosides, their production and use
DE69034119T2 (de) Substituierte-1,3-Oxathiolane mit antiviraler Wirkung
AT390000B (de) Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten
DE69233631T2 (de) 1,3-Oxathiolane zur Behandlung von Hepatitis
DD255351A5 (de) Verfahren zur herstellung von carbocyclischen purinnucleosiden
EP0286028A2 (de) Desaza-purin-nucleosid-Derivate, Verfahren zu deren Herstellung sowie deren Verwendung bei der Nucleinsäure-Sequenzierung sowie als antivirale Mittel
EP0626387A1 (de) Nukleoside und Oligonukleotide mit 2'-Ethergruppen
WO1993016091A1 (de) Neue liponucleotide, deren herstellung sowie deren verwendung als antivirale arzneimittel
EP0679657A2 (de) Nukleoside und Oligonukleotide mit 2'-Ethergruppen
DD297650A5 (de) Verfahren zur herstellung von fluor-substituierten purin-nucleosiden und sie enthaltender pharmazeutischer zubereitungen
CH626363A5 (ja)
WO1992003462A1 (de) Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
DE2915254A1 (de) Neue chemische verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel mit antiviraler wirkung
EP0003229A1 (de) Neues Verfahren zur Herstellung von Nucleosiden
CH676712A5 (ja)
DE3044740C2 (ja)
DE3390162T1 (de) Desoxyuridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
EP0219838A2 (en) Carbocyclic purine nucleosides, their production and use
EP0015584A2 (de) Neue Nukleotide, Verfahren zu ihrer Herstellung und Arzneimittel
EP0452680B1 (de) Substituierte Purine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel
DD251984A5 (de) Verfahren zur herstellung von 3'-azidonucleosiden und pharmazeutisch vertraeglichen derivaten davon
DD287406A5 (de) Therapeutische nucleoside
EP0464642A1 (de) Pyrimidin-Derivate, deren Herstellung und Verwendung sowie diese enthaltende Arzneimittel
CA1278517C (en) Antiviral composition
DD274424A5 (de) Verfahren zur herstellung einer verbindung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee